EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy

PURPOSE: This study was conducted to evaluate the relationship between epidermal growth factor receptor (EGFR) mutation and clinical outcomes in patients with stage III non-squamous cell lung cancer treated with definitive concurrent chemoradiotherapy (CCRT). MATERIALS AND METHODS: From January 2008...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Res Treat
Main Authors: Park, Song Ee, Noh, Jae Myoung, Kim, You Jin, Lee, Han Sang, Cho, Jang Ho, Lim, Sung Won, Ahn, Yong Chan, Pyo, Hongryull, Choi, Yoon-La, Han, Joungho, Sun, Jong-Mu, Lee, Se Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Format: Artigo
Jezik:Inglês
Izdano: Korean Cancer Association 2019
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6473280/
https://ncbi.nlm.nih.gov/pubmed/29914238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2018.125
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki